GELS · Gelteq Ltd
United States · RS rating 8 · As of 2026-10-14
| Price | 0.45 USD |
|---|---|
| 1-day change | -6.2% |
| RS rating (overall / 1M / 3M / 12M) | 8 / 7 / 16 / 9 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 16 / 1 |
| Industry group (rank) | Medical-Generic Drugs (94) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +70.6% |
| Market cap (USD) | $7.2M |